Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condizione: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Da: Revaluation Books, Exeter, Regno Unito
EUR 108,99
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 9.29x6.34x0.51 inches. In Stock.
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2019
ISBN 10: 0323678963 ISBN 13: 9780323678964
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 123,05
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Lingua: Inglese
Editore: Elsevier Health Sciences Sep 2019, 2019
ISBN 10: 0323678963 ISBN 13: 9780323678964
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 108,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover 'Treat to Target in Rheumatic Diseases? with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 120,56
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover 'Treat to Target in Rheumatic Diseases? with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.